Share on StockTwits

Rite Aid (NYSE:RAD) EVP Robert Ivan Thompson unloaded 25,566 shares of the stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $7.03, for a total value of $179,728.98. Following the completion of the sale, the executive vice president now directly owns 749,882 shares of the company’s stock, valued at approximately $5,271,670. The sale was disclosed in a filing with the SEC, which is available at this link.

RAD has been the subject of a number of recent research reports. Analysts at Zacks upgraded shares of Rite Aid from a “hold” rating to a “buy” rating in a research note on Tuesday. Separately, analysts at Deutsche Bank raised their price target on shares of Rite Aid from $7.00 to $9.00 in a research note on Monday. They now have a “buy” rating on the stock. Finally, analysts at Raymond James raised their price target on shares of Rite Aid from $7.00 to $8.00 in a research note on Friday, April 11th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Rite Aid presently has an average rating of “Buy” and a consensus target price of $7.69.

Rite Aid (NYSE:RAD) traded up 0.56% on Friday, hitting $7.16. The stock had a trading volume of 26,040,336 shares. Rite Aid has a one year low of $2.33 and a one year high of $7.39. The stock has a 50-day moving average of $6.64 and a 200-day moving average of $5.77. The company has a market cap of $6.852 billion and a P/E ratio of 31.50.

Rite Aid (NYSE:RAD) last announced its earnings results on Thursday, April 10th. The company reported $0.10 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.04 by $0.06. The company had revenue of $6.60 billion for the quarter, compared to the consensus estimate of $6.54 billion. During the same quarter last year, the company posted $0.13 earnings per share. Rite Aid’s revenue was up 2.2% compared to the same quarter last year. On average, analysts predict that Rite Aid will post $0.39 earnings per share for the current fiscal year.

Rite Aid Corporation is a retail drugstore chain in the United States. In the Company’s stores, it sells prescription drugs and a range of other merchandise, which it calls front end products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.